drugset
Drugs / Multiple Signals loaded Dendritic Cells Vaccine
last change Apr 2022 re-read 3 minutes ago

Multiple Signals loaded Dendritic Cells Vaccine

Cell therapy

Developed for
hepatocellular carcinoma
Investigated by
Nanfang Hospital, Southern Medical University · Sun Yat-sen University · Yuehua Huang

Trials 1

today NCT04317248 · Ph 2
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04317248 Apr 2020 → Apr 2022 hepatocellular carcinoma Yuehua Huang Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Multiple Signals loaded Dendritic Cells Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT04317248 ↗
Modality Cell therapy “Multiple Signals loaded Dendritic Cells Vaccine” NCT04317248 ↗
Route Intravenous “intravenous drip” NCT04317248 ↗